Download original image
Fig. 3. Effects of the high, intermediate, and low Torsades de Pointes risk drugs on action potential (AP) waveforms in human induced pluripotent stem cell-derived cardiomyocytes. Representative ventricular-type AP traces in the control and in the presence of 14.69 μM sotalol (A), 0.03 μM chlorpromazine (B), and 2.5 μM mexiletine (C).
Korean J Physiol Pharmacol 2023;27:267-275
© Korean J Physiol Pharmacol